Targeting mitochondrial complex II and TCA cycle enhance the anti-cancer effects of kinase inhibitor in leukemia.

○Takuya Hirao

[27P2-pm2-134] Targeting mitochondrial complex II and TCA cycle enhance the anti-cancer effects of kinase inhibitor in leukemia.

○Takuya Hirao¹, Taiki Ichinose¹, Kana Tanabe¹, Tatsuya Emonoto¹, Shigeki Aoki³, Chihiro Tetsuka^1,2, Yoshinori Kato^1,2, Harumi Yamada^1,2 (1. Sch. Pharm. Sci., Int. Univ. Health and Welfare, 2. Grad. Sch. Pharm. Sci., Int. Univ. Health and Welfare, 3. Grad. Sch. Pharm. Sci., Chiba Univ.)

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.

Presentation information

[27P2-pm2] Clinical Pharmacy 3

[27P2-pm2-134] Targeting mitochondrial complex II and TCA cycle enhance the anti-cancer effects of kinase inhibitor in leukemia.

Password